Home › Funds › Farallon Capital Management › CCCC
Farallon Capital Management position in CCCC
C4 THERAPEUTICS INC · Health Care
Latest position (Q1 2026)28.00K sh
Reported value held$73.64K
Portfolio Weight0.00%
First reportedQ1 2024
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 28.00K | $228.76K | New |
| Q2 2024 | 28.00K | $129.36K | Hold |
| Q3 2024 | 28.00K | $159.60K | Hold |
| Q4 2024 | 28.00K | $100.80K | Hold |
| Q1 2025 | 28.00K | $44.80K | Hold |
| Q2 2025 | 28.00K | $40.04K | Hold |
| Q3 2025 | 28.00K | $62.16K | Hold |
| Q4 2025 | 28.00K | $53.48K | Hold |
| Q1 2026 | 28.00K | $73.64K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CCCC
- Morgan Stanley 8.87M sh · $41.41M · Q2 2026
- BlackRock Inc 7.90M sh · $36.88M · Q2 2026
- JPMorgan Chase & Co 4.75M sh · $20.65M · Q2 2026
- Citadel Advisors 4.28M sh · $20.01M · Q2 2026
- Goldman Sachs Group 3.53M sh · $16.49M · Q2 2026
- Two Sigma Investments 3.47M sh · $16.20M · Q2 2026
- Bank of America Corp 2.66M sh · $12.41M · Q2 2026
- Geode Capital Management 2.52M sh · $11.78M · Q2 2026
- Vanguard Group 4.38M sh · $8.37M · Q4 2025
- D. E. Shaw & Co 1.74M sh · $8.13M · Q2 2026
- Renaissance Technologies 1.19M sh · $5.56M · Q2 2026
- Northern Trust Corp 1.16M sh · $5.42M · Q2 2026